Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parkinson's disease and thyroid dysfunction.

Renato P Munhoz1, Helio A G Teive, André R Troiano

  • 1Department of Neurology, Hospital de Clínicas, Federal University of Paraná, Rua General Carneiro 181, 12th floor, 80060-900 Curitiba, PR, Brazil.

Parkinsonism & Related Disorders
|July 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ataxia Global Initiative recommend MRI end-points for clinical trials in ataxias.

Nature reviews. Neurology·2026
Same author

Longitudinal Dynamics of Polyglutamine-Expanded ATXN3 in Biofluids of Spinocerebellar Ataxia Type 3.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Ozzy Osbourne and Parkinson's disease: from darkness to awareness.

Arquivos de neuro-psiquiatria·2026
Same author

"Expert Commentary on Segmental brainstem myoclonus in ADCK3-related ataxia".

Parkinsonism & related disorders·2026
Same author

Cerebral palsy in art and literature throughout history.

Arquivos de neuro-psiquiatria·2026
Same author

Isaac Newton's description of the optic chiasm.

Arquivos de neuro-psiquiatria·2026
Same journal

Cerebellum crus II cortical thickness as a cognitive brain reserve in Parkinson's disease.

Parkinsonism & related disorders·2026
Same journal

Serious games and virtual reality in Parkinson's disease rehabilitation: A systematic review of randomized controlled trials.

Parkinsonism & related disorders·2026
Same journal

Respiratory-swallow training in Parkinson's disease: Effects of a single session on swallowing safety and efficiency with exploratory comparisons of biofeedback.

Parkinsonism & related disorders·2026
Same journal

Levodopa responsive childhood-onset generalized dystonia with diaphragmatic involvement associated with an SPTBN2 variant.

Parkinsonism & related disorders·2026
Same journal

Approach to a case of Neuro-Gonadal disorder: Perrault syndrome.

Parkinsonism & related disorders·2026
Same journal

Parakinesia in Chorea: Why attribution of intention is misleading.

Parkinsonism & related disorders·2026
See all related articles

This study found no significant difference in hypothyroidism prevalence between Parkinson's disease (PD) patients and controls. However, assessing thyroid function is crucial due to overlapping symptoms and levodopa's effects.

Area of Science:

  • Neurology
  • Endocrinology
  • Clinical Research

Background:

  • Parkinson's disease (PD) and hypothyroidism share overlapping symptoms, potentially causing diagnostic delays.
  • No established causal link exists between PD and hypothyroidism.

Purpose of the Study:

  • To evaluate thyroid function in individuals diagnosed with Parkinson's disease.
  • To determine if hypothyroidism is more prevalent in PD patients compared to a healthy control group.

Main Methods:

  • A cohort of 95 Parkinson's disease patients and 102 age-matched controls underwent clinical assessment.
  • Laboratory screening was performed to evaluate thyroid function in all participants.

Main Results:

  • Hypothyroidism was detected in 13.7% of PD patients and 10.8% of controls.

Related Experiment Videos

  • Statistical analysis revealed no significant difference in hypothyroidism rates between the two groups (p = 0.3681).

    • Conclusions:

    • Hypothyroidism is not significantly more prevalent in Parkinson's disease patients.
    • Thyroid function screening is recommended for PD patients with unexplained symptom exacerbation.
    • Consider levodopa's acute impact on thyroid-stimulating hormone (TSH) levels during screening.